Casa Physicians Alliance News


Sanofi TENIVAC Supply Status


November 2016

Dear Healthcare Provider, 

Sanofi Pasteur is experiencing a manufacturing delay with TENIVAC® (Tetanus and Diphtheria Toxoids Adsorbed) and will therefore not be able to supply TENIVAC vaccine. This supply disruption is related to unanticipated delays in manufacturing facility upgrades. It is expected that supply will improve in the second half of 2017. Please note that this does not impact the supply of   Adacel ® a  vaccine,   Pentacel ® b  vaccine, or DAPTACEL® c  vaccine.

As an alternative, you may consider using a   Tdap   vaccine, such as   Adacel   vaccine, for eligible patients. The ACIP recommends that all eligible adults 19 years of age and older receive a single dose of   Tdap   vaccine. 1  Despite this long-standing recommendation, the CDC estimates that 78.5% of adults 19-64 years of age have not yet been vaccinated with   Tdap   vaccine. 2

Sanofi Pasteur recognizes the challenges we face when we are unable to obtain the vaccine of choice and the impact this has on our business .  Thank you for your understanding and we look forward to continuing to partner with you for your immunization needs.

 Should you require assistance locating alternative sources of Td vaccine or need additional information, please visit Sanofi Pasteur’s website at   www.vaccineshoppe.com,  contact your Sanofi Pasteur sales representative, or call their Customer Service representatives at 1-800-VACCINE (1-800-822-2463).

IMPORTANT SAFETY INFORMATION FOR TENIVAC VACCINE
Known hypersensitivity ( eg , anaphylaxis) to a previous dose of TENIVAC vaccine or any other tetanus or diphtheria toxoid‐containing vaccine is a contraindication. Because of uncertainty as to which component of the vaccine may be responsible, no further vaccination with diphtheria or tetanus components should be carried out.

The tip caps of the prefilled syringes may contain natural rubber latex that may cause allergic reactions in latex sensitive individuals.

If  Guillain‐Barré syndrome has occurred within 6 weeks following previous vaccination with a tetanus toxoid containing vaccine, the decision to give TENIVAC vaccine should be based on careful consideration of the potential benefits and possible risks.

Persons who experienced  Arthus‐type hypersensitivity reactions following a prior dose of tetanus toxoid containing vaccine should not receive TENIVAC vaccine less than 10 years since the last dose of tetanus toxoid containing vaccine.

The most common local and systemic adverse reactions to TENIVAC vaccine include erythema, tenderness, and swelling at the injection site; headache, malaise, and fever. Other adverse reactions may occur. Vaccination with TENIVAC vaccine may not protect all individuals.

INDICATION FOR TENIVAC VACCINE

TENIVAC vaccine is indicated for active immunization for prevention of tetanus and diphtheria. TENIVAC vaccine is approved for use in persons 7 years of age and older.

IMPORTANT SAFETY INFORMATION FOR ADACEL VACCINE
Known hypersensitivity ( eg, anaphylaxis) to a previous dose of  Adacel vaccine or any other tetanus toxoid, diphtheria toxoid, or pertussis antigen-containing vaccine, or to any component; or encephalopathy within 7 days after a previous dose of a pertussis-containing vaccine with no other identifiable cause, is a contraindication.

The tip caps of the prefilled syringes may contain natural rubber latex that may cause allergic reactions in latex-sensitive individuals.

If  Guillain-Barré syndrome or brachial neuritis has occurred within 6 weeks following previous vaccination with a tetanus toxoid-containing vaccine, if progressive or unstable neurologic disorders exist, or if adverse events have occurred in temporal relation to receipt of pertussis antigen-containing vaccine, the decision to give  Adacel vaccine should be based on careful consideration of the potential benefits and risks.

Persons who experienced an  Arthus-type hypersensitivity reaction following a prior dose of tetanus toxoid-containing vaccine should not receive  Adacel vaccine unless at least 10 years have elapsed since the last dose of tetanus toxoid-containing vaccine.

Syncope (fainting) can occur in association with administration of injectable vaccines, including  Adacel vaccine. Procedures should be in place to prevent falling injury and manage syncopal reactions.

The most common local and systemic adverse reactions to  Adacel vaccine include pain, erythema, and swelling at the injection site; headache, body ache or muscle weakness, and tiredness. Other adverse reactions may occur. Vaccination with  Adacelvaccine may not protect all individuals.

INDICATION FOR ADACEL VACCINE
Adacel vaccine is indicated for active booster immunization for the prevention of tetanus, diphtheria, and  pertussis. Adacel  vaccine  is  approved  for  use  as  a  single  dose  in  individuals  10  through  64 years  of age.

Before administering  TENIVAC or  Adacel  vaccine, please see full prescribing information.

a Adacel (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed).  b Pentacel (Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and  Haemophilus b Conjugate [Tetanus Toxoid Conjugate] Vaccine).
cDAPTACEL (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed).

References: 1 Centers for Disease Control and Prevention (CDC). Preventing tetanus, diphtheria, and pertussis among adults: use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP) and Recommendations of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC) for use of  Tdap among health-care personnel. MMWR. 2006 ;55(RR-17):1-37. 2. CDC. Vaccination coverage among adult population – United States, 2014. MMWR. 2016 ;61(25):468.

MKT31472-2

Posted by Shari Smith on 17th November, 2016 | Comments | Trackbacks
Tags: Tentanus and Diphtheria Toxoids Adsorbed, Pentacel, TENIVAC, Group Purchasing Organization, CASA Physicians Alliance, Adacel, Daptacel, Discount Vaccines, Discount Buying Opportunity, Discount Sanofi Vaccines, Discount Vaccine Buying Program, Discount Vaccine Program, Vaccine Discounts and Rebates, vaccine, Purchasing Program, Vaccine Group, Vaccine Savings, Sanofi, Physicians Buying Group, Savings on Pediatric Vaccines, Sanofi Pasteur, Savings on Adolescent Vaccines, Savings on Adult Vaccines

Bookmark and Share

The trackback URL for this page is http://www.casa.en.asenz2biz.asenz360.com/trackback?post=32906252


Trackbacks

There are no trackbacks for this post


Comments

There are no comments for this post


Post a Comment

HTML is not allowed in comments, http://... will be automatically linked.


Name (required):


Email Address (not displayed):


Comment (required):


To help prevent spam, please enter the word acts here:

CASA Physicians Alliance - A Group Purchasing Organization for Physicians, was started 16 years ago for the sole purpose of joining physicians into a large buying group to obtain the best possible discounts on pediatric, adolescent and adult vaccines. Since then, CASA has forged very successful partnerships on behalf of our members.


Archives

May 2018
April 2018
February 2018
August 2017
January 2017
November 2016
October 2016
August 2016
July 2016
June 2016
April 2016
February 2016
January 2016
October 2015
September 2015
August 2015
July 2015
May 2015

Tags

ACIP MenB Recommendations (4)
Adacel (3)
Adult Vaccine (7)
Age 16-23 years vaccinations (2)
CASA Discount on Trumenba (2)
CASA Physicians Alliance (21)
CASA Physicians Alliance - Trumenba Discount (4)
CASA offers Discounts on Trumenba (2)
CDC (1)
CDC Recommendation for Trumenba at Rutgers (1)
Cleanovative Solutions (1)
Daptacel (3)
Discount Buying Opportunity (7)
Discount Sanofi Vaccines (10)
Discount Vaccine Buying Program (8)
Discount Vaccine Program (11)
Discount Vaccines (12)
Discounts on RotaTeq Vaccine (1)
Discounts on Trumenba vaccine (2)
EVI (1)
Flu Vaccine (5)
FluMist (2)
Gardasil 9 (2)
Group Purchasing Organization (10)
Hand Sanitizer (1)
Healthcare Professional (14)
IPOL (2)
Influenza (9)
Influenza Vaccine (11)
Medical Buying Group (11)
Medical and Surgical Supplies (2)
Medimmune (2)
Menactra (3)
Meningococcal B Rutgers Outbreak (1)
Meningococcal B Vaccine (8)
Merck (2)
Merck - GARDASIL®9 (1)
Merck - GARDASIL®9 (2)
Merck - GARDASIL®9 (1)
National Council for Aging Care (1)
Office Depot (1)
Office Supplies (1)
One Stop Shop (6)
Patient Notifications (4)
Pediatric Vaccine (7)
Pentacel (1)
Pfizer (7)
Pfizer Trumenba Recommended for Rutgers (1)
Physicians Buying Group (20)
Physicians Buying Group offering Discount on Trumenba Vaccine (4)
Purchasing Program (5)
Quadrivalent Flu Vaccine (10)
Quadrivalent Influenza Vaccine (9)
RotaTeq (1)
Rotavirus Vaccine (1)
Rutgers University Trumenba Recommendation (1)
Sanofi (6)
Sanofi Flu Partners Program (10)
Sanofi Fluzone (11)
Sanofi Pasteur (12)
Sanofi Pasteur Flu Vaccine (10)
Savings on Adolescent Vaccines (8)
Savings on Adult Vaccines (10)
Savings on Pediatric Vaccines (9)
Savings on Trumenba (4)
Schedule your Flu Shot (10)
Seasonal Flu (11)
Seasonal Flu for Seniors (1)
Serogroup B Meningococcal MenB vaccine Trumenba (2)
State of New Jersey Dept of Health Trumenba Recommendation for Rutgers Students (1)
TENIVAC (1)
TVFC (3)
Tentanus and Diphtheria Toxoids Adsorbed (1)
Texas Vaccines for Children (3)
Trumenba Discounts (7)
Trumenba Info (3)
Trumenba MenB Vaccine (4)
Trumenba Promotion (8)
Trumenba Recommendation (2)
Trumenba Serogroup B vaccine (2)
Trumenba Two Dose Prescribing Information (3)
Vaccinate Early (7)
Vaccination Recommendation Trumenba (2)
Vaccine Coding (5)
Vaccine Discounts and Rebates (13)
Vaccine Group (6)
Vaccine Group Purchasing Program (13)
Vaccine Inventory System (1)
Vaccine Reimbursement (6)
Vaccine Savings (13)
VaxServe (2)
Vendor Promotion (2)
Vital Oxide (1)
Zylast (1)
vaccine (14)